Concepedia
Statistics
Publications
31
Citations
1.3K
H-Index
18
Active since
2009
Affiliations
Kyoto University(Current)
Foundation for Biomedical Research and Innovation
Kobe City Medical Center General Hospital
Kansai Medical University
Kyoto University Hospital
Hiroki Nagai is an author at Kyoto University specializing in oncology, medicine, and lung cancer.
Publications per year
2009–2023
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
Yosuke Togashi, Katsuhiro Masago, Satohiro Masuda et al. · Cancer Chemotherapy and Pharmacology · 2012 · 283 citations · Full text
Medicine, Oncology, Pharmacology +12
Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis
Takuji Okusaka, Masahiro Yoshida, Masayuki Kitano et al. · International Journal of Clinical Oncology · 2023 · 171 citations · Full text
Medicine, Oncology, Surgery +17
Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients
Takashi Nomizo, Hiroaki Ozasa, Takahiro Tsuji et al. · Scientific Reports · 2017 · 119 citations · Full text
Medicine, Genetics, Oncology +17
Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer
Yoshihisa Kobayashi, Koichi Azuma, Hiroki Nagai et al. · Molecular Cancer Therapeutics · 2016 · 77 citations
Medicine, Oncology, Pharmacology +17
Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model
Takahiro Tsuji, Hiroaki Ozasa, Wataru Aoki et al. · Molecular Cancer Research · 2018 · 47 citations · Full text
1–5 of 31